PTSD Trauma and Stressor-Related
Researchers found that significant improvement in symptoms of posttraumatic stress disorder is associated with a lower risk for type 2 diabetes among veterans.
Increased risk seen in cohort of young and middle-aged veterans in unadjusted and fully adjusted models.
The long-term benefits of pharmacologic treatments were inferior to those of psychotherapeutic and combined treatments across 6 randomized clinical trials reviewed by investigators.
A machine learning algorithm trained on electroencephalographic coherence can predict transcranial magnetic stimulation treatment outcome for patients with major depressive disorder and posttraumatic stress disorder.
Some individuals are at a substantially increased risk for mental health problems after mild traumatic brain injury.
Palo Alto Health Sciences announced that the FDA has granted clearance to Freespira, a new digital therapeutic for the treatment of PTSD.
Giving patients with post-traumatic stress disorder (PTSD) their preferred treatment improves adherence and symptoms.
Patients with PTSD should consider concurrent treatment with evidence-based psychotherapy to maximize their chances for meaningful improvement.
This research supports the use of mindfulness-based stress reduction as a treatment method for veterans with PTSD.
The authors argue that these findings suggest that reducing shame among veterans with post-traumatic stress disorder may reduce the risk for suicide.
Acting in the capacity of a surrogate decision maker can lead to emotional distress and poor health-related quality of life.
Want to read more?
Please login or register first to view this content.
Next post in PTSD trauma and stressor-related